Work

O-186 Mutations in EGFR, HER2, KRAS and BRAF in NSCLC: Prevalences and correlations with clinical outcomes in patients treated with carboplatin and paclitaxel with or without erlotinib

Year: 2005
Type: conference-abstract
Source: Lung Cancer
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W1977781452
Cites:
Cited by:
Related to: 10